MET vs UMBF
MetLife Inc. vs UMB Financial Corp. — AI-powered side-by-side comparison
VS
UMBF
UMB Financial Corp.
69
Buy
| Metric | MET | UMBF |
| AI Score |
56
|
69
|
| Price |
$96.67
|
$143.73
|
| P/E Ratio |
18.26×
|
11.88×
|
| ROE |
11.9%
|
9.1%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
25.6%
|
58.5%
|
| Debt / Equity |
0.74×
|
0.44×
|
| Dividend Yield |
2.4%
|
1.2%
|
| RSI (14) |
50.1
|
32.1
|
| Beta |
0.763
|
0.788
|
| Expected Upside |
—
|
—
|
AI Committee View
Current Innellis committee reasoning for MET versus UMBF.
UMBF leads by 13 points.
UMBF scores 69/100 (Buy) versus MET at 56/100 (Buy).
MET Committee View
50% agreement
6 analysts
The committee is genuinely divided. Macro Analyst sees a compelling case. Risk Analyst remains cautious — current ratio of 0.19 is tight -- limited short-term liquidity cushion. This disagreement is itself the signal — the setup is not clean in either direction.
Bull Case
- Dividend yield of 3.3% pays you to wait — Value
- 4 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
Bear Case
- EPS declining -11.0% YoY despite any revenue growth — Growth
- MACD histogram negative -- bearish momentum — Technical
- Current ratio of 0.19 is tight -- limited short-term liquidity cushion — Risk
UMBF Committee View
100% agreement
6 analysts
The primary driver is p/e of 12.1 is inexpensive for the broad market. The main limiting factor is sector concentration is already high (hhi 3068.56). The committee is constructive but not yet at full conviction.
Bull Case
- P/E of 12.1 is inexpensive for the broad market — Value
- Price-to-book of 1.1x is a discount to asset value — Value
- Revenue growing 72.2% YoY -- genuine top-line momentum — Growth
Bear Case
- Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
- MACD histogram negative -- bearish momentum — Technical